Picture of Cellid Co logo

299660 Cellid Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Cellid Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue009094800
Cost of Revenue
Gross Profit009091550
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses3,5315,28713,92015,39111,904
Operating Profit-3,531-5,287-13,011-14,911-11,904
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-2,494-4,126-13,071-22,865-11,611
Provision for Income Taxes
Net Income After Taxes-2,494-4,126-13,071-22,865-11,611
Net Income Before Extraordinary Items
Net Income-2,494-4,126-13,071-22,865-11,611
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-2,494-4,126-13,071-22,865-11,611
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-232-374-1,176-2,052-1,105
Dividends per Share